Wednesday, September 26, 2012
KYTHERA Biopharmaceuticals Sets IPO Pricing Range
Calabasas-based KYTHERA Biopharmaceuticals, a venture-backed developer of aesthetic medicine products, has set its IPO pricing range, saying earlier this week that it is expectings its IPO price to be between $14.00 and $16.00 per share. KYTHERA is looking to list on the NASDAQ Global Market as KYTH. Kythera is venture backed by Versant Ventures, ARCH Ventures, Prospect Venture Partners, JAFCO, Fidelity, and others. KYTHERA is offering up 4M shares of its common stock in the offering. The pricing range is among one of the steps in the IPO process, and usually happens as a part of a company's IPO roadshow and efforts to set its IPO price. Kythera filed for its IPO in May.